Primary hormonal resistance of prostate cancer: clinical and morphological aspects

Abstract

By using the routine studies, the authors have analyzed clinical and morphological data of 129 prostate cancer (PC) patients, 48-92 years old with different clinical stages. PC turned out to be initially heterogenic in the composition of tumor cells (cytotypic and immunophenotypic heterogenicity). Therefore combined PC treatment should take into account the presence of hormone-resistant tumor cells even when a neoplasm looks at the light microscopy as a usual low- or moderate-grade adenocarcinoma with a great number of adrenoceptors in the tumor cells.